Pharma & Biotech

A significant policy development from the U.S. Food and Drug Administration (FDA) is creating a favorable environment for companies developing...

The telehealth provider Hims & Hers finds itself navigating turbulent regulatory waters. Its recent expansion into the multi-billion dollar testosterone...

CorMedix Inc. is executing a series of strategic financial maneuvers, including a significant investment in Talphera and substantial stock sales...

Gossamer Bio shares are commanding significant market attention, fueled by a notable spike in speculative trading and a wave of...

Evolus Inc. shares experienced a notable decline of 4.26% during Friday's trading session, closing at $7.19. This downward movement coincided...

Advanced Micro Devices (AMD) finds itself navigating contrasting narratives as it pursues leadership in artificial intelligence while facing intensified examination...

Investors are reassessing Viking Therapeutics' clinical trial data as concerns emerge about patient discontinuation rates in the study of oral...

Despite delivering a series of positive developments, including new product launches and robust quarterly results, OrthoPediatrics shares are experiencing significant...

Intercept Pharmaceuticals faces a severe market downturn after the biopharma firm initiated a voluntary withdrawal of its key medication, Ocaliva,...

Shares of Australian biotechnology firm Mesoblast Limited experienced significant downward momentum in recent trading sessions. The company's stock listed on...